CACLP 2027 Exhibitor List Released, Bringing Together Leading IVD Companies and Innovators in Nanjing

With preparations for CACLP 2027 progressing, the official exhibitor list has been released, offering an early look at the companies and innovations set to gather at the 24th China International In Vitro Diagnostics Expo (CACLP 2027). Taking place from 19–21 March 2027 at the Nanjing International Expo Center in Nanjing, Jiangsu Province, China, the exhibition will once again bring together leading IVD manufacturers, emerging innovators, and industry professionals from across the global diagnostics community.

A Comprehensive Showcase of the IVD Industry

The newly released exhibitor list highlights the breadth of the exhibition, spanning the entire IVD value chain, from established diagnostic sectors to emerging fields in life sciences, consumer healthcare, and intelligent diagnostics, while reflecting the industry's evolving technologies and business opportunities.

（CACLP 2027 Exhibitor Preview）

Exhibited products and solutions will include:

- Instruments and Reagents for Clinical Laboratory: Hematology and body fluid testing, clinical chemistry, immunology, microbiology, molecular diagnostics, and POCT.

- Instruments and Reagents for Pathology: Cytopathology, histopathology, immunohistochemistry, and molecular pathology.

- Instruments and Reagents for Transfusion Medicine.

- Instruments and Reagents for Scientific Research.

- Life Sciences and Biotechnology.

- Consumer Healthcare & At-home Testing.

- AI-powered Smart Healthcare Products.

- Raw materials, core components, consumables, manufacturing equipment, and R&D solutions.

From core laboratory diagnostics and upstream technologies to consumer healthcare and AI-powered applications, CACLP 2027 will provide a comprehensive platform for discovering products, technologies, and business opportunities across the industry.

Highlights of CACLP 2027

1.      Expanding Industry Boundaries and Emerging Market Segments

CACLP 2027 will further expand its exhibition scope through two key areas, reflecting the growing convergence of IVD with upstream material innovation, pharmaceutical R&D, and precision medicine.

- Advanced Materials: Focusing on innovation in key materials across the industry value chain, this segment will highlight upstream technologies and solutions while strengthening integration between materials suppliers and the IVD industry. 

- Diagnostics and Pharmaceutical R&D Integration: Highlighting the convergence of diagnostic technologies with innovative drug development, companion diagnostics, and related applications, creating new opportunities for collaboration between diagnostics and pharmaceutical industries.

2.     Advancing AI and Intelligent Healthcare Technologies

Building on the growing integration of AI into laboratory medicine and diagnostics, CACLP 2027 will present an upgraded showcase of technologies shaping intelligent laboratories and future healthcare.

Featured applications will include:

- AI-powered diagnostics and AI Agent applications.

- Smart laboratories, automation, and digitalized testing workflows.

- Regional laboratory testing solutions.

- Intelligent transportation and medical logistics.

- Emergency testing and other innovative healthcare applications.

3.     An Upgraded 2,000 sqm Consumer Healthcare & At-home Testing Pavilion

The Consumer Healthcare & At-home Testing Pavilion will be significantly expanded in 2027, covering approximately 2,000 sqm and bringing together more than 200 companies.

The dedicated pavilion will showcase the full consumer healthcare ecosystem, with a focus on home testing, personal health management, and emerging consumer-oriented medical technologies.

Four dedicated functional areas will integrate product displays, brand promotion, business matchmaking, and industry exchange, providing exhibitors with opportunities to connect with distributors, retail channels, and potential partners.

4.    Connecting International Resources and Supporting Global Expansion

International cooperation remains an important focus of CACLP 2027. The exhibition will continue to expand its overseas buyer programme, bringing more international distributors and purchasing representatives to Nanjing.

Through international buyer delegations, business matchmaking, and global industry networking activities, CACLP aims to facilitate direct connections between Chinese IVD manufacturers and overseas buyers.

5. An Enhanced Exhibition Experience and More Connected Industry Networking

CACLP 2027 will further improve the experience for exhibitors and visitors, creating a more comfortable and engaging environment for professional exchange.

Key initiatives include:

- Upgraded Business Networking Spaces: Improved business meeting areas and VIP lounges to facilitate more efficient communication and business discussions.

- Nanjing City Connections: Cultural activities introducing international guests and industry professionals to Nanjing's traditional culture and local heritage.

6. Advancing ESG Practices for a Greener Exhibition

CACLP 2027 will continue to promote environmental responsibility and sustainable exhibition practices, working towards a greener and more resource-efficient event.

Key initiatives include:

- Noise-Controlled Halls: Improving the exhibition environment through noise-control measures to create more comfortable and efficient spaces for professional communication.

- ESG Construction: Encouraging the use of ecofriendly materials and reusable booth structures to reduce construction costs, improve resource efficiency, and promote sustainable exhibition development.

（CACLP 2027 Venue Layout）

A Comprehensive Programme of Industry Conferences and Business Activities

Alongside the exhibition, CACLP 2027 will host a series of academic conferences, industry forums, business matchmaking sessions, and networking activities.

Key themes will include AI and Digital Twin Medicine, Consumer Healthcare & At-home Testing, Primary Healthcare, IVD Globalization, and Veterinary Diagnosis.

Bringing together clinical experts, researchers, industry leaders, and business representatives from China and overseas, these activities will provide platforms for professional discussion, knowledge exchange, and industry collaboration.

For more information, visit en.caclp.com.

About CACLP

With over 30 years of industry expertise, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the global in vitro diagnostic industry. Each year, it brings together 40,000 professionals —including entrepreneurs, scholars, end users, and thought leaders from around the world—to exchange insights, foster partnerships, and collectively shape the future of IVD.

The event covers the entire diagnostics value chain from upstream to downstream, offering a comprehensive showcase of products, technologies, and services. Alongside a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP serves as a vital platform for global IVD players.

About GL events

Founded in Lyon in 1978, GL events is world-class leading provider of integrated solutions and services for events operating. GL events’ business covers more than 20 countries across five continents, with over 90 branches and more than 6,000 employees. GL events is listed on the Euronext Paris Segment B in 1998.

Through the unique business model – a complementary mix of products and services addressing the needs of all events and customer expectations.

-   LIVE: provide comprehensive solutions from design to deliver events, 6,000 events served annually.

-   VENUES: provide venues layout and operation, venues management, technical support, and more customized services, more than 60 venues under management.

-   EXHIBITIONS: plan and organize tradeshows to bring together B2B & B2C communities, with 480 proprietary exhibitions.